Immunization status of the 23-valent pneumococcal polysaccharide vaccine among elderly aged 65 and older in South Korea

被引：0
|
作者：
Kim, Jeong Ah [1 ]
Won, Heehyun [1 ]
Jeong, Na-Young [2 ]
Choi, Nam-Kyong [1 ]
机构：
[1] Ewha Womans Univ, Dept Hlth Convergence, Coll Sci & Ind Convergence, Seoul, South Korea
[2] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
628
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [31] Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
    Vila-Corcoles, Angel
    Ochoa-Gondar, Olga
    Guzman, Jorge A.
    Rodriguez-Blanco, Teresa
    Salsench, Elisabet
    Fuentes, Cruz M.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [32] Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
    Kazunari Satomura
    Toshitaka Nakahara
    Suketaka Iwanaga
    Megumi Noami
    Keiko Kusaka
    Kazuyoshi Harano
    BMC Health Services Research, 14 (Suppl 2)
  • [33] Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
    Angel Vila-Corcoles
    Olga Ochoa-Gondar
    Jorge A Guzmán
    Teresa Rodriguez-Blanco
    Elisabet Salsench
    Cruz M Fuentes
    BMC Infectious Diseases, 10
  • [34] IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS
    Muravyeva, N.
    Belov, B.
    Baranova, M.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 854 - 855
  • [35] Use of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions:Recommendations of the Advisory Committee on Immunization Practices
    宁桂军
    中国疫苗和免疫, 2014, (02) : 187 - 188
  • [36] Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China
    Sun, Xiaodong
    Guo, Xiang
    Qiu, Jing
    Zhao, Genming
    Xu, Xinxin
    Wagner, Abram L.
    Jiang, Hongli
    Huang, Zhuoying
    Ren, Jia
    Ma, Xiaoying
    Liang, Xiufang
    Yao, Yao
    Wu, Jialing
    Lu, Yihan
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [37] EVALUATION OF PNEUMOCOCCAL TITERS AND RESPONSE TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN WITH COUGH
    Anthony, K.
    Urrego, F.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S78 - S78
  • [38] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices
    Kaye, Donald
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (01)
  • [39] Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
    Rose, MA
    Schubert, R
    Strnad, N
    Zielen, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (10) : 1216 - 1222
  • [40] Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and Older
    Zhu, Zhongkui
    Sun, Jianwen
    Xie, Yan
    Lu, Xi
    Tang, Wanqin
    Zhao, Yanwei
    Shen, Lu
    Liu, Huaxian
    Yu, Yang
    Zhou, Siliang
    Huo, Liqun
    Jiao, Peng
    Jiang, Xiaoli
    VACCINES, 2024, 12 (08)
12345